We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

96 hedge funds and large institutions have $223M invested in BioSpecifics Technologies Corp. in 2016 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 34 increasing their positions, 37 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 9

29% more capital invested

Capital invested by funds: $174M → $223M (+$49.8M)

7% more funds holding

Funds holding: 90 → 96 (+6)

8% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 37

Holders
96
Holders Change
+6
Holders Change %
+6.67%
% of All Funds
2.4%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
16
Increased
34
Reduced
37
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NI
Numeric Investors
Massachusetts
+$7.41M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.48M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.45M
4
MCM
Matarin Capital Management
New York
+$1.45M
5
BFA
BlackRock Fund Advisors
California
+$1.23M

Top Sellers

Rank Fund Capital Flow
1
RCMC
RK Capital Management (Colorado)
Colorado
-$3.74M
2
DCM
DAFNA Capital Management
California
-$1.81M
3
RA
Royce & Associates
New York
-$1.47M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$877K
5
BCM
Bridgeway Capital Management
Texas
-$846K
Name Holding Trade Value Shares
Change 		Change in
Stake
VKH
101
Virtu KCG Holdings
New York
– -$225K -4,937 Closed
TSS
102
Two Sigma Securities
New York
– -$209K -4,575 Closed
CCMH
103
Cornerstone Capital Management Holdings
New York
– -$177K -3,900 Closed
PCM
104
Prelude Capital Management
New York
– -$50K -1,100 Closed
MFS
105
MSI Financial Services
Massachusetts
– -$3K -74 Closed
1 2 3 4
5

BSTC Hedge Fund Activity: Q4 2016 in Review

96 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q4 2016, worth a combined $223M — up 29% from $174M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new BSTC positions and 9 closed out — a net gain of 7 holders — while 34 added to existing stakes and 37 trimmed.

The largest buyer was Numeric Investors, opening a new position worth an estimated $7.41M. The largest seller was RK Capital Management (Colorado), cutting an estimated $3.74M.

  • 96 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q4 2016, up from 90 in Q3 2016.
  • Funds reported $223M of BioSpecifics Technologies Corp. stock for Q4 2016, up 29% quarter-over-quarter.
  • 16 funds opened new BioSpecifics Technologies Corp. positions in Q4 2016 and 9 closed out, a net change of +7 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q4 2016 was Numeric Investors, an estimated $7.41M added.
  • The largest BioSpecifics Technologies Corp. seller in Q4 2016 was RK Capital Management (Colorado), an estimated $3.74M sold.

Based on aggregated 13F filings for Q4 2016.